TELSARTAN H 14

About

Telsartan H combines Telmisartan, an angiotensin II receptor blocker (ARB), with Hydrochlorothiazide (HCTZ), a thiazide diuretic. Telmisartan works by blocking the action of angiotensin II, a potent vasoconstrictor, leading to relaxation of blood vessels and a decrease in blood pressure. Hydrochlorothiazide enhances this effect by increasing the excretion of sodium and water from the body, further reducing blood volume and blood pressure. This combination is particularly effective for patients whose blood pressure is not adequately controlled by monotherapy.

This dual-action medication provides comprehensive blood pressure control, reducing the risk of cardiovascular events such as stroke and heart attack. It is often prescribed when a single agent is insufficient to achieve target blood pressure levels, offering a synergistic effect to manage hypertension more effectively and improve patient outcomes.

Uses

• Treatment of essential hypertension.
• Management of high blood pressure when monotherapy is inadequate.
• Reduction of cardiovascular risk in hypertensive patients.
• Prevention of stroke and heart attack in high-risk individuals.

Directions For Use

Take one tablet orally once daily, with or without food, or as directed by your healthcare provider.

Benefits

• Effective reduction of high blood pressure.
• Dual mechanism of action for enhanced control.
• Reduces risk of major cardiovascular events.
• Once-daily dosing for patient convenience.
• May help manage fluid retention.
• Well-tolerated in many patients.

Side Effects

• Dizziness
• Lightheadedness
• Fatigue
• Headache
• Nausea
• Diarrhea
• Muscle cramps
• Electrolyte imbalance (e.g., hypokalemia)
• Increased uric acid levels
• Photosensitivity
• Hypotension
• Upper respiratory tract infection

Safety Measures

• Alcohol - Alcohol may increase the hypotensive effect and risk of dizziness. Use with caution and avoid excessive consumption.
• Pregnancy - Contraindicated in the second and third trimesters due to risk of fetal harm (renal dysfunction, oligohydramnios, fetal death).
• Breastfeeding - Not recommended during breastfeeding as both components may pass into breast milk and potentially harm the infant.
• Liver - Use with caution in patients with severe hepatic impairment; dosage adjustment may be necessary, and there's an increased risk of hepatic coma with HCTZ.
• Kidney - Use with caution in patients with severe renal impairment or renal artery stenosis; monitor kidney function closely. HCTZ is less effective in severe renal dysfunction.
• Lung - Generally safe for use in patients with lung conditions, as it does not typically cause respiratory side effects.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.